Amalgamated Bank’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-95
Closed -$2K 2646
2025
Q4
$2K Sell
95
-33
-26% -$852 ﹤0.01% 2921
2025
Q3
$4K Hold
128
﹤0.01% 2862
2025
Q2
$4K Hold
128
﹤0.01% 2876
2025
Q1
$4K Hold
128
﹤0.01% 2749
2024
Q4
$4K Hold
128
﹤0.01% 2809
2024
Q3
$4K Hold
128
﹤0.01% 2850
2024
Q2
$4K Hold
128
﹤0.01% 2884
2024
Q1
$5K Sell
128
-409
-76% -$15.3K ﹤0.01% 2738
2023
Q4
$22K Sell
537
-38
-7% -$1.22K ﹤0.01% 2610
2023
Q3
$18K Hold
575
﹤0.01% 2711
2023
Q2
$23K Buy
+575
New +$23.5K ﹤0.01% 2684

Other funds holding SMTI

Amalgamated Bank's SMTI Position: Q1 2026 in Review

Amalgamated Bank sold out of Sanara MedTech (SMTI) in Q1 2026, closing a stake of 95 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in SMTI in Q2 2023 and held it in 11 quarters. The position peaked at $23K in Q2 2023. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • Amalgamated Bank reported no remaining Sanara MedTech position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 95 Sanara MedTech shares in Q1 2026, an estimated $2K.
  • Amalgamated Bank first reported a position in Sanara MedTech in Q2 2023 and held it in 11 quarters.
  • Amalgamated Bank's Sanara MedTech position peaked at $23K in Q2 2023.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.